Technical Analysis for NSCI - Netscientific Plc

Grade Last Price % Change Price Change
D 63.00 0.00% 0.00
NSCI closed unchanged on Friday, April 26, 2024, on 52 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Flat

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
Hammer Candlestick Bullish 0.00%
Doji - Bearish? Reversal 0.00%
Doji - Bullish? Reversal 0.00%
200 DMA Support Bullish 0.00%
Doji - Bearish? Reversal 0.00%
200 DMA Support Bullish 0.00%
Hammer Candlestick Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Doji - Bearish? Reversal 0.00%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low about 16 hours ago
Down 3% about 16 hours ago
Down 2% about 16 hours ago
Down 1% about 16 hours ago
Fell Below 200 DMA about 16 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Netscientific Plc Description

NetScientific plc is a transatlantic healthcare technology company. The Company develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the United States and Europe with a primary focus on diagnostics, digital health and therapeutics. The Company is engaged in the development of intellectual property. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients; Glucosense, a provider of a non-invasive glucose monitoring wearable device; Vortex Biosciences, which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing; Glycotest, which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis, and ProAxsis, which is engaged in respiratory disease diagnosis and treatment monitoring.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Healthcare Medicine Science Cancer Disease Ships Monitoring Clinical Medicine Analytics Earl Identification Partnerships Intellectual Property Machine Learning Blood Healthcare Technology Respirator Tumor Cancers Learning Respiratory Disease E Learning Fibrosis Heart Failure Blood Tests Circulating Tumor Cell Congestive Heart Failure Liver Cancer

Is NSCI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 78.75
52 Week Low 48.0
Average Volume 28,455
200-Day Moving Average 62.04
50-Day Moving Average 66.74
20-Day Moving Average 63.78
10-Day Moving Average 63.20
Average True Range 2.49
RSI (14) 43.82
ADX 17.16
+DI 13.73
-DI 22.23
Chandelier Exit (Long, 3 ATRs) 61.72
Chandelier Exit (Short, 3 ATRs) 65.48
Upper Bollinger Bands 67.87
Lower Bollinger Band 59.68
Percent B (%b) 0.41
BandWidth 12.83
MACD Line -1.07
MACD Signal Line -1.15
MACD Histogram 0.0831
Fundamentals Value
Market Cap 15.09 Million
Num Shares 23.9 Million
EPS -0.13
Price-to-Earnings (P/E) Ratio -484.62
Price-to-Sales 12.03
Price-to-Book 0.85
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 66.00
Resistance 3 (R3) 65.67 64.33 65.50
Resistance 2 (R2) 64.33 63.57 64.50 65.33
Resistance 1 (R1) 63.67 63.10 64.00 64.00 65.17
Pivot Point 62.33 62.33 62.50 62.50 62.33
Support 1 (S1) 61.67 61.57 62.00 62.00 60.83
Support 2 (S2) 60.33 61.10 60.50 60.67
Support 3 (S3) 59.67 60.33 60.50
Support 4 (S4) 60.00